New blood test could spot breast cancer earlier
NCT ID NCT07266194
First seen Dec 16, 2025
Summary
This study will check how well a new blood test, called SpotitEarly, can detect breast cancer in women. About 500 women will take part, including those at higher risk due to age, genetics, or family history. The goal is to see if the test is accurate and works well for different groups, like different ages and races.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER DETECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- No-Squeeze 3D breast scan could transform cancer detection
- New scan could sharpen breast cancer staging
- New blood test could spot breast cancer early, saving lives
- AI matches radiologists in breast cancer screening study
- Researchers work with communities to make breast cancer screening easier in nigeria
- Donate your mammogram to train AI for better breast cancer detection